Bit's 8th Annual World Cancer Congress - 2015
★ Program Layout

BIT’s 8th World Cancer Congress-2015
Theme: Bridging Research and Practice
Time: May 15-17, 2015
Venue: Beijing, China

Program Layout

Track 1: Opening Ceremony and Keynote Forum

Track 2: Cancer Hospital Administrators Forum

Track 3: Cancer Screen, Prevention and Control

Track 4: Breaking Research of Oncology

Track 5: Cancer Prognostics and Diagnostics

Track 6: Cancer Drug Discovery and Development

Track 7: Best Clinical Practice on Cancer

Track 8: Cancer Therapies

 

Preliminary Program

Track 1: Opening Ceremony and Keynote Forum

Part 1: Opening Ceremony

Part 2: Keynote Forum

Track 2: Cancer Hospital Administrators Forum

The session will cover the following topics, but not limited...
Topic1: Cancer Hospital President Forum
Topic2: Hospital Transdisciplinary Collaboration
Topic3: Clinical Trial Dos & Donts for Partnering with Pharma
Topic4: Seeking Administrative/Financial Efficiencies with IT Support
Topic5: Cancer Hospital Quality Assurance & Training

Track 3: Cancer Screen, Prevention and Control

Session 301: Cancer Screening, Monitoring, and Counseling for High-Risk Populations

Session 302: Cancer Epidemiology Biostatistics and Prevention

Session 303: Physical, Psychological and Social Impacts and Cancer Prevention

Session 304: Diet, Circadian Rhythm, Metabolism and Cancer Prevention

Track 4: Breaking Research of Oncology

Session 401: Genetic, Cellular and Tissue Markers in Tumors

Session 402: Circulating, Disseminated Tumor Cells and Metastasis

Session 403: Apoptosis, Autophagy, Cell Death and Cancers

Session 404: Cancer/Tumor Microenvironment Interactions

Session 405: Model Organisms and Animal Models of Cancer Research

Session 406: Angiogenesis and Cancers

Session 407: Emerging Promising Pathways in Cancer Research

Session 408: Cancer Metabolism and Metabolic Pathways

Session 409: Molecular Carcinogenesis, Oncogenes and Tumor Suppressors (Part I)

Session 410: Cancer Genomic Heterogeneity and Instability

Session 411: Molecular Carcinogenesis, Oncogenes and Tumor Suppressors (Part II)

Session 412: DNA Damage, Cancers, and DNA Repair

Session 413: MicroRNAs and Long Noncoding RNAs in Cancers

Session 414: Cancer Epigenetics

Track 5: Cancer Prognostics and Diagnostics

Session 501: Cancer Prognostic Biomarkers and Predictive Factors (Part I)

Session 502: Current and Emerging Cancer Diagnostic Technologies and Tests

Session 503: Cancer Prognostic Biomarkers and Predictive Factors (Part II)

Session 504: Cancer Molecular Imaging and Nuclear Oncology

Session 505: Molecular Pathology/Cytopathology Approaches, Tissue and Cell-based Cancer Diagnostics

Track 6: Cancer Drug Discovery and Development

Session 601: New Cancer Target Identification and Validation

Session 602: Lead Discovery and Optimization

Session 603: Anticancer Drug Candidates Toxicity and Efficacy in Animal Models

Session 604: Anticancer Drug Clinical Trial

Track 7: Best Clinical Practice on Cancer

Part 7-1: Medical Research on Tumors

Session 701: Head, Neck, Brain Cancers, and CNS Tumors

Session 702: Nasopharyngeal, Eye and Oral Cancers

Session 703: Breast Cancer

Session 704: Ovarian and Cervical Cancer

Session 705: Prostate Cancer

Session 706: Pancreatic and Gastrointestinal Cancer

Session 707: Melanoma and Other Skin Tumors

Part 7-2: Cancer Nursing and Cares

Part 7-3: Latest Advances and Research in Surgical Oncology

Track 8: Cancer Therapies

Session 801: Chemotherapy, Photodynamic Therapy, Radiotherapy, Proton Beam Therapy and Hyperthermia Approaches

Session 802: New Horizons in Cancer Biotherapy

Session 803: Cancer Immunotherapy

Session 804: Targeted Cancer Therapies

Session 805: Combination Therapy, Complementary and Alternative Medicine vs Traditional Chinese Medicine

Session 806: Interventional Techniques in Cancer

News Released

1. The world Well-known Overseas Cancer Research Center, e.g. Institut Gustave Roussy、UC San Diego Moores Cancer Center、The UT MD Anderson Cancer Center、University of Texas Health Science Center, have sent representatives to attend the WCC-2015

2. The well-known Chinese universities and hospitals, e.g. Chinese Academy of Science, Peking University, Fudan University, Sun Yat-sen University Cancer Center have sent representatives to attend the WCC-2015

3. Dr. Yi Zeng, the academician of Chinese Academy of Sciences and the world renowned virologist with more than 50 years’ research experience in virology, has confirmed to attend WCC-2015

4. Dr. Thomas Tursz, the Honorary Director of Institut Gustave Roussy, the largest cancer research institute in Europe, has confirmed to attend WCC-2015

5. Dr. Yuxin Yin, Director, Institute of Systems Biomedicine, Peking University, has confirmed to attend WCC-2015

6. Dr. Stephen J. O'Brien, the co-founder of the international Comparative Genomics field, has confirmed to attend WCC-2015

7. Many Overseas Medias and Journals are achieving cooperation with WCC-2015 in contribution.

Hosting Organization

Information Research Center of International Talents, SAFEA

Operating Organization

BIT Congress Inc.

Foreign Experts Databank of SAFEA-Dalian Branch

National
Honorary Chairman


Dr. Yi Zeng
Professor & Dean
Beijing University of Technology & Chinese Academy of Science, China

International
Honorary Chairman


Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France


Dr. Stephen J. O’Brien
Chief Scientific Officer
Theodosius Dobzhansky Center for Genome Bioinformatics
St. Petersburg State University, Russia

Chairman


Dr. Huabei Chen,
Director
State Administration of Foreign Experts Affairs, China

Conference Proceedings Publishing Journal (ISSN 2330-4049)
Official Travel Agency

BIT World Travel Service, Inc.

BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.